Withings
PrivateLast Round
Series B
Jul 28, 2020
Est. Valuation
$192M
Total Funding Raised
$93.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Withings operates in Consumer & Commerce and is based in Issy-les-Moulineaux. Its latest recorded funding round was a Series B round in July 2020.
Withings is a consumer electronics company that develops and manufactures connected health devices, including smart scales, hybrid smartwatches, blood pressure monitors, and sleep analyzers.
Sector
Consumer & Commerce
Verticals
Consumer Electronics, Medical Devices, Health IoT, Sports & Fitness, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Withings Comparables
Compare Withings with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oura | 78% | |
| Alphabet Inc. | 77% | |
| Renpho | 77% |
For institutional investors. Book with your work email.
Withings Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 28, 2020 | ||||
| Buyout/LBO | May 31, 2018 | ||||
| M&A | May 31, 2016 | ||||
| Series A | Jul 17, 2013 | ||||
| Seed | Sep 2, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Withings Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 360 Capital | Series A |
| Idinvest Partners | Series A, Series B |
| BNP Paribas Développement | Series B |
| 360 Capital | Series A |
| ODDO BHF Private Equity | Series B |
| Eurazeo Investment Manager | Series B |
| Gilde Healthcare | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 10, 2026
New Cardio Program aimed at increasing adoption among cardiologists.
- May 10, 2026
New ACCESS program aligns with Centers for Medicare & Medicaid Services.
For institutional investors. Book with your work email.
Withings Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Withings's valuation, stock price, and market status.
Is Withings a public or private company?
Withings is a private company.
What is the current stock price of Withings?
Withings is a private company, so its shares have no public market price. Caplight tracks Withings's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Withings worth (valuation)?
Withings's valuation is estimated at $192.0M based on funding round data.
Can I buy Withings stock?
Withings shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Withings's last funding round?
Withings's most recent funding round was Series B on July 28, 2020.
Who are the main investors in Withings?
Key investors in Withings include Idinvest Partners, Eurazeo Investment Manager, Gilde Healthcare, Ventech, Bpifrance.
Will Withings IPO soon?
No public IPO plans have been announced for Withings.
How can I track Withings secondary market activity?
Caplight tracks bids, offers, and trades in Withings's shares on secondary markets.